Patent 10947300 was granted and assigned to Massachusetts Institute of Technology on March, 2021 by the United States Patent and Trademark Office.
The present invention provides antibodies (e.g., monoclonal antibodies, human antibodies, humanized antibodies, etc.), which bind to multiple influenza strains. Such antibodies are useful, for example, in the prophylaxis, treatment, diagnosis, and/or study of influenza.